Cargando…
Cancer Stem Cells as a Source of Drug Resistance in Bone Sarcomas
Bone sarcomas are commonly characterized by a high degree of intra-tumor heterogeneity, which in part is due to the presence of subpopulations of tumor cells presenting stem cell properties. Similar to normal stem cells, these cancer stem cells (CSCs) display a drug resistant phenotype and therefore...
Autores principales: | Menéndez, Sofía T., Gallego, Borja, Murillo, Dzohara, Rodríguez, Aida, Rodríguez, René |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8232081/ https://www.ncbi.nlm.nih.gov/pubmed/34198693 http://dx.doi.org/10.3390/jcm10122621 |
Ejemplares similares
-
Addressing Doxorubicin Resistance in Bone Sarcomas Using Novel Drug-Resistant Models
por: Gallego, Borja, et al.
Publicado: (2022) -
Exploring the Use of Cold Atmospheric Plasma to Overcome Drug Resistance in Cancer
por: Murillo, Dzohara, et al.
Publicado: (2023) -
Nano-Encapsulation of Mithramycin in Transfersomes and Polymeric Micelles for the Treatment of Sarcomas
por: Estupiñán, Óscar, et al.
Publicado: (2021) -
Proof of concept for the use of trained sniffer dogs to detect osteosarcoma
por: Ortal, Agustín, et al.
Publicado: (2022) -
GARP promotes the proliferation and therapeutic resistance of bone sarcoma cancer cells through the activation of TGF-β
por: Carrillo-Gálvez, Ana Belén, et al.
Publicado: (2020)